The head of Johnson & Johnson (J&J) Innovation in Europe says the region is ripe for more life sciences investment, but warns that the UK, its biotech leader, could miss out without gre
Anyone who has taken a psychiatric medication knows that the status quo in prescribing is a trial and error approach, with patients often cycling through an array of drugs to find the one t
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.